Viking Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell VKTX and other ETFs, options, and stocks.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
CEOBrian Lian
CEOBrian Lian
Employees27
Employees27
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees27
Employees27
VKTX Key Statistics
Market cap8.31B
Market cap8.31B
Price-Earnings ratio-82.18
Price-Earnings ratio-82.18
Dividend yield—
Dividend yield—
Average volume2.94M
Average volume2.94M
High today$78.22
High today$78.22
Low today$73.41
Low today$73.41
Open price$78.13
Open price$78.13
Volume1.38M
Volume1.38M
52 Week high$99.41
52 Week high$99.41
52 Week low$8.28
52 Week low$8.28
VKTX News
Benzinga 2d
Check Out What Whales Are Doing With VKTX - Viking Therapeutics - BenzingaLoading... Loading... Whales with a lot of money to spend have taken a noticeably bullish stance on Viking Therapeutics. Looking at options history for Viking...
Yahoo Finance 6d
Viking Therapeutics, Inc. Q1 2024 Earnings Call Transcript - Yahoo FinanceViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript April 24, 2024 Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is...
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%